JHL Biotech announced that Max Chan will join the company as Chief Financial Officer effective October 20, 2015. He will also oversee business development, public relations, and investor relations. Mr. Chan joins the company from TaiGen Biopharmaceuticals, where during his five-year tenure as Chief Financial Officer he facilitated the company's initial public offering in Taiwan.